Google DeepMind launched AlphaGenome, an AI tool that predicts how DNA mutations disrupt gene regulation.
The system analyses up to one million DNA letters at once to assess mutation impact.
Researchers trained it on human and mouse genetic databases.
AlphaGenome helps identify disease-driving mutations linked to cancer, heart disease, and autoimmune disorders.
Scientists say it could speed drug discovery and enable targeted gene therapies.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
OMN AI
This article was created with the assistance of OMN AI, the AI-powered editorial platform developed by OMN Group. Every article is reviewed, fact-checked, and approved by a human journalist before publication to ensure accuracy and editorial quality. Learn more at https://omngroup.com
Keep Reading
Add A Comment
Golden Gate Times delivers powerful stories, breaking news, sports, and culture—bringing bold perspectives and timely updates to keep readers informed, inspired, and connected worldwide.
We’re social. Connect with us:
© 2026 Golden Gate Times. All Rights Reserved.
